期刊文献+

谷氨酸循环障碍在抑郁症发病机制中的作用及治疗 被引量:2

原文传递
导出
摘要 过去的40年间,抑郁症研究主要聚焦于单胺神经递质系统,这让我们加深了对抑郁症病理生理机制的理解.近来,越来越多的研究证据显示,抑郁症的发病机制可能与谷氨酸循环障碍有关.并且,近来的一些药理学研究也显示,多种谷氨酸受体调节剂具有抗抑郁作用[1].当这些发现为谷氨酸受体的配体具有抗抑郁作用提供推动力时,调节突触问谷氨酸的代谢清除机制可能也会提供可行的药物靶点.我们将就谷氨酸循环的生理特点、其在抑郁症中可能的病理生理作用,及以增强谷氨酸再摄取作为抗抑郁药新靶点的治疗学进展进行综述.
出处 《中华精神科杂志》 CAS CSCD 北大核心 2011年第3期187-189,共3页 Chinese Journal of Psychiatry
基金 国家自然科学基金面上项目(30770779)
  • 相关文献

参考文献35

  • 1Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev, 2009,61:105-123.
  • 2Kugaya A, Sanacora G. Beyond monoamines : glutamatergic function in mood disorders. CNS Spectr, 2005,10:808-819.
  • 3Valentine GW, Sanacora G. Targeting glial physiology and glutamate cycling in the treatment of depression. Biochem Pharmacol, 2009,78:431 439.
  • 4Kim JS, Schmid-Burgk W, Claus D, et al. Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr, 1982, 232 : 299-504.
  • 5Ahamura CA, Mauri MC, Ferrara A, et al. Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry, 1993,150 : 1731-1733.
  • 6Mitani H, Shirayama Y, Yamada T, et al. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry, 2006, 30:1155-1158.
  • 7Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry, 2007, 62 : 1310-1316.
  • 8Perry TL, Hansen S, Gandham SS. Postmortem changes of amino compounds in human and rat brain. J Neurochem, 1981,36:406- 410.
  • 9Sanacora G, Gueorguieva R, Epperson CN, et al. Subtype- specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry, 2004,61: 705-713.
  • 10Castillo M, Kwock L, Courvoisie H, et al. Proton MR spectroscopy in children with bipolar affective disorder : preliminary observations. AJNR Am J Neuroradiol, 2000,21:832- 838.

同被引文献42

  • 1李则挚,苑成梅,吴志国,易正辉,洪武,陈俊,王勇,胡莺燕,曹岚,黄佳,方贻儒.双相障碍抑郁发作与单相抑郁症的临床特征比较[J].上海交通大学学报(医学版),2011,31(11):1513-1517. 被引量:22
  • 2黄佳,苑成梅,方贻儒.双相障碍早期识别的研究进展[J].上海交通大学学报(医学版),2011,31(11):1550-1553. 被引量:11
  • 3王勇,方贻儒.抑郁症神经生化机制的研究进展[J].上海交通大学学报(医学版),2007,27(4):461-464. 被引量:9
  • 4Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Neurosci ,2006,7 : 137-151.
  • 5世界卫生组织.ICD-10《精神与行为障碍分类》临床描述与诊断要点.第1版.北京:人民卫生出版社,1993.110.
  • 6Castren E. Is mood chemistry? Nat Rev Neurosci ,2005,6:241-246.
  • 7XU L. Neuralplasticity mechanism of depression. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2008,33:326-330.
  • 8Maeng S, Zarate Jr CA, Du J, et al. Cellular mechanis underlying the an- tidepressant effects of ketamine : Role of [ alpha ] -Amino-3-Hydroxxy-5- Methylisoxazole-4-Propionic acid receptors. Biological Psychiatry, 2008, 63:349-352.
  • 9Mitani H, Shirayama Y, Yamada T, et al. Correlation between plasma levels of glutamate,alanine and serine with severity of depression. Prog Neumpsychophannacol Biol Psychiatry ,2006,30 : 1155-1158.
  • 10Valentine GW, Sanacom G. Targeting glial physiology and glutam tecy- cling in the treatment of depression. Biochem Pharmacol, 2009,78 : 431-439.

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部